Rep. Richard McCormick Sells UnitedHealth Group Incorporated (NYSE:UNH) Shares

Representative Richard McCormick (R-Georgia) recently sold shares of UnitedHealth Group Incorporated (NYSE:UNH). In a filing disclosed on October 09th, the Representative disclosed that they had sold between $1,001 and $15,000 in UnitedHealth Group stock on September 18th. The trade occurred in the Representative’s “GROWTH PARTNERS ROTH IRA” account.

Representative Richard McCormick also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Microsoft (NASDAQ:MSFT) on 9/18/2025.
• Sold $1,001 – $15,000 in shares of L3Harris Technologies (NYSE:LHX) on 9/18/2025.
• Sold $1,001 – $15,000 in shares of BlackRock (NYSE:BLK) on 9/18/2025.

UnitedHealth Group Price Performance

UNH stock opened at $367.69 on Friday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The business has a 50 day simple moving average of $315.87 and a 200-day simple moving average of $351.51. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The company has a market capitalization of $333.01 billion, a P/E ratio of 15.93, a PEG ratio of 2.39 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same period in the prior year, the business earned $6.80 earnings per share. UnitedHealth Group’s revenue for the quarter was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were issued a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.4%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is presently 38.30%.

Analysts Set New Price Targets

Several brokerages recently weighed in on UNH. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of UnitedHealth Group in a report on Wednesday. Royal Bank Of Canada cut their price objective on UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating for the company in a research report on Wednesday, July 30th. Piper Sandler cut their price objective on UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating for the company in a research report on Wednesday, July 30th. Sanford C. Bernstein increased their price objective on UnitedHealth Group from $379.00 to $433.00 and gave the stock an “outperform” rating in a research report on Wednesday. Finally, JPMorgan Chase & Co. increased their price objective on UnitedHealth Group from $310.00 to $425.00 and gave the stock an “overweight” rating in a research report on Thursday. Sixteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have assigned a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $383.09.

Institutional Trading of UnitedHealth Group

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in UNH. Net Worth Advisory Group boosted its position in UnitedHealth Group by 0.6% during the first quarter. Net Worth Advisory Group now owns 3,642 shares of the healthcare conglomerate’s stock valued at $1,907,000 after buying an additional 21 shares during the period. Bensler LLC boosted its position in UnitedHealth Group by 0.3% during the first quarter. Bensler LLC now owns 6,945 shares of the healthcare conglomerate’s stock valued at $3,637,000 after buying an additional 22 shares during the period. Lakeridge Wealth Management LLC boosted its position in UnitedHealth Group by 5.8% during the first quarter. Lakeridge Wealth Management LLC now owns 420 shares of the healthcare conglomerate’s stock valued at $220,000 after buying an additional 23 shares during the period. Nabity Jensen Investment Management Inc boosted its position in UnitedHealth Group by 0.9% during the first quarter. Nabity Jensen Investment Management Inc now owns 2,760 shares of the healthcare conglomerate’s stock valued at $1,446,000 after buying an additional 24 shares during the period. Finally, BigSur Wealth Management LLC boosted its position in UnitedHealth Group by 0.5% during the first quarter. BigSur Wealth Management LLC now owns 4,743 shares of the healthcare conglomerate’s stock valued at $2,484,000 after buying an additional 25 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

About Representative McCormick

Rich McCormick (Republican Party) is a member of the U.S. House, representing Georgia’s 7th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

McCormick (Republican Party) is running for re-election to the U.S. House to represent Georgia’s 7th Congressional District. He declared candidacy for the 2026 election.

Rich McCormick lives in Suwanee, Georgia. McCormick served in the U.S. Marine Corps and the U.S. Navy. He earned an M.B.A. from National University and an M.D. from Morehouse School of Medicine. McCormick’s career experience includes working as an emergency medicine physician with Gwinnett Medical Center and Northside Hospital, a Marine officer instructor with Georgia Tech and Morehouse College, and a pilot.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.